Skip to search formSkip to main contentSkip to account menu

MVAC Regimen

Known as: Methotrexate-Vinblastine-Adriamycin-Cisplatin Regimen 
A regimen consisting of methotrexate, vinblastine, doxorubicin and cisplatin used for the treatment of advanced-stage bladder cancer.
National Institutes of Health

Related topics

Related topics

6 relations
Carcinoma of bladderCisplatinDoxorubicinM-VAC protocol

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
Systemtherapie des metastasierten Tumors des oberen Harntraktes
ZusammenfassungHintergrundMehr als 95 % der Tumoren des oberen Harntraktes (OHT) sind korrespondierend zum Harnblasenkarzinom… 
2015
2015
Exceptional Response to Pazopanib in a Patient with Urothelial Carcinoma Harboring FGFR3 Activating Mutation and Amplification.
2012
2012
INTENSIFIED METHOTREXATE, VINBLASTINE, DOXORUBICIN AND CISPLATIN (I-MVAC) WITH OR WITHOUT PANITUMUMAB AS FIRST-LINE TREATMENT OF ADVANCED UROTHELIAL CARCINOMA IN PATIENTS WITHOUT H-Ras NOR K-Ras…
2007
2007
Chemotherapy for advanced transitional cell carcinoma of the urothelium: cisplatin or carboplatin?
2006
2006
Internationale Studie zum Blasentumor
EORTC 30994: randomisierte Phase-IIIStudie zum Vergleich einer sofortigen gegen eine verzögerte Chemotherapie nach radikaler… 
2006
2006
Complete long-term survival data from a trial of adjuvant chemotherapy vs control after radical cystectomy for locally advanced bladder cancer
Review
2004
Review
2004
Potentially New And Innovative Treatments For Superficial, Muscle-Invasive, And Metastatic Transitional Cell Carcinoma (TCC) Of The Bladder
Purpose: To present a novel,innovative treatment for superficial, muscle-invasive and metastatic transitional cell carcinoma (TCC… 
Review
2000
Review
2000
Gemcitabine and cisplatin in locally advanced and/or metastatic bladder cancer.
Review
2000
Review
2000
Progress in the management of metastatic bladder cancer.
BACKGROUND Inadequate survival results from single agents in the management of advanced bladder cancer have prompted several… 
Review
1995
Review
1995
Management of bladder cancer.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)